[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341242-105":59,"doc-detail-341242-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","epithelial-cell-adhesion-molecule-epcam-expression-in-human-tumors-a-comparison-with-pan-cytokeratin-and-trop2-in-14832-tumors","Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 Tumors","","EpCAM is expressed across many epithelial tumors and is used to help distinguish malignant mesotheliomas from adenocarcinomas, serving as a surrogate pan-epithelial marker. An immunohistochemical tissue microarray containing 14,832 samples from 120 tumor categories compared EpCAM staining with TROP2 and CKpan. EpCAM staining was detected in 99 tumor categories, with EpCAM positivity rates ≥90% in 60 categories among 78 epithelial tumor types. EpCAM showed particularly low expression in hepatocellular carcinomas, adrenocortical tumors, renal cell neoplasms, and poorly differentiated carcinomas. Concordance between EpCAM and CKpan was high, while differences emerged for testicular seminomas and neuroendocrine neoplasms versus hepatocellular carcinomas, mesotheliomas, and poorly differentiated nonneuroendocrine tumors. Compared with TROP2, higher TROP2 positivity occurred in squamous cell carcinomas and lower rates in many gastrointestinal adenocarcinomas and other tumor groups, supporting EpCAM’s diagnostic utility.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epithelial-cell-adhesion-molecule-epcam-expression-in-human-tumors-a-comparison-with-pan-cytokeratin-and-trop2-in-14832-tumors/341242/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epithelial-cell-adhesion-molecule-epcam-expression-in-human-tumors-a-comparison-with-pan-cytokeratin-and-trop2-in-14832-tumors/341242.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is EpCAM used for in tumor diagnosis?","Question",{"text":113,"@type":114},"EpCAM is expressed in many epithelial tumors and is used to distinguish malignant mesotheliomas from adenocarcinomas as a surrogate pan-epithelial marker.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was EpCAM expression measured in the study?",{"text":118,"@type":114},"A tissue microarray with 14,832 samples from 120 tumor categories was analyzed by immunohistochemistry, and EpCAM staining was compared with TROP2 and CKpan.",{"name":120,"@type":111,"acceptedAnswer":121},"In which tumor types did EpCAM show the lowest staining rates?",{"text":122,"@type":114},"EpCAM staining was lowest in hepatocellular carcinomas, adrenocortical tumors, renal cell neoplasms, and poorly differentiated carcinomas.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341242,1790864863,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","diagnostics  \nArticle  \nEpithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 Tumors  \nAnne Menz 1, Nora Lony 1, Maximilian Lennartz 1, Sebastian Dwertmann Rico 1, Ria Schlichter 1, Simon Kind 1, Viktor Reiswich 1, Florian Viehweger 1, David Dum 1, Andreas M. Luebke 1, Martina Kluth 1,  \nNatalia Gorbokon 1, Claudia Hube-Magg 1, Christian Bernreuther 1, Ronald Simon 1, *, Till S. Clauditz 1, Guido Sauter 1, Andrea Hinsch 1, Frank Jacobsen 1, Andreas H. Marx 2, Stefan Steurer 1, Sarah Minner 1,  \nEike Burandt 1, Till Krech 1,3, Patrick Lebok 1,3 and Sören Weidemann 1  \nCitation: Menz, A.; Lony, N.;  \nLennartz, M.; Dwertmann Rico, S.; Schlichter, R.; Kind, S.; Reiswich, V.; Viehweger, F.; Dum, D.; Luebke, A.M.; et al. Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 Tumors. Diagnostics 2024, 14, 1044 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)diagnostics14101044  \nAcademic Editor:  \nFrancesca Sanguedolce  \nReceived: 2 April 2024  \nRevised: 26 April 2024  \nAccepted: 30 April 2024  \nPublished: 17 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany;  \n[a.menz@uke.de](a.menz@uke.de) (A.M.); [nora_lony@hotmail.de](nora_lony@hotmail.de) (N.L.); [m.lennartz@uke.de](m.lennartz@uke.de) (M.L.);  \n[s.dwertmann-rico@uke.de](s.dwertmann-rico@uke.de) (S.D.R.); [r.schlichter@uke.de](r.schlichter@uke.de) (R.S.); [s.kind@uke.de](s.kind@uke.de) (S.K.); [v.reiswich@uke.de](v.reiswich@uke.de) (V.R.);  \n[f.viehweger@uke.de](f.viehweger@uke.de) (F.V.); [d.dum@uke.de](d.dum@uke.de) (D.D.); [luebke@uke.de](luebke@uke.de) (A.M.L.); [m.kluth@uke.de](m.kluth@uke.de) (M.K.);  \n[n.gorbokon@uke.de](n.gorbokon@uke.de) (N.G.); [c.hube@uke.de](c.hube@uke.de) (C.H.-M.); [c.bernreuther@uke.de](c.bernreuther@uke.de) (C.B.); [t.clauditz@uke.de](t.clauditz@uke.de) (T.S.C.);  \n[g.sauter@uke.de](g.sauter@uke.de) (G.S.); [a.hinsch@uke.de](a.hinsch@uke.de) (A.H.); [f.jacobsen@uke.de](f.jacobsen@uke.de) (F.J.); [s.steurer@uke.de](s.steurer@uke.de) (S.S.);  \n[s.minner@uke.de](s.minner@uke.de) (S.M.); [e.burandt@uke.de](e.burandt@uke.de) (E.B.); [t.krech@uke.de](t.krech@uke.de) (T.K.); [p.lebok@uke.de](p.lebok@uke.de) (P.L.);  \ns.weidemann@uke.de (S.W.)  \n2 Department of Pathology, Academic Hospital Fuerth, 90766 Fuerth, Germany; [andreas.marx@klinikum-fuerth.de](andreas.marx@klinikum-fuerth.de)  \n3 Institute of Pathology, Clinical Center Osnabrueck, 49076 Osnabrueck, Germany  \n* Correspondence: [r.simon@uke.de](r.simon@uke.de); Tel.: +49-40-7410-57214  \nAbstract: EpCAM is expressed in many epithelial tumors and is used for the distinction of malignant mesotheliomas from adenocarcinomas and as a surrogate pan-epithelial marker. A tissue microarray containing 14,832 samples from 120 different tumor categories was analyzed by immunohistochemistry. EpCAM staining was compared with TROP2 and CKpan. EpCAM staining was detectable in 99 tumor categories. Among 78 epithelial tumor types, the EpCAM positivity rate was ≥90% in 60 categories—including adenocarcinomas, neuroendocrine neoplasms, and germ cell tumors. EpCAM staining was the lowest in hepatocellular carcinomas, adrenocortical tumors, renal cell neoplasms, and in poorly differentiated carcinomas. A comparison of EpCAM and CKpan staining identified a high concordance but EpCAM was higher in testicular seminomas and neuroendocrine neoplasms and CKpan in hepatocellular carcinomas, mesotheliomas, and poorly differentiated nonneuroendocrine ","cbCaimPXIhu3KGlN","https://ap.wps.com/l/cbCaimPXIhu3KGlN","pdf",4193762,17,"English","# Introduction\n## EpCAM overview and signaling\n## Evidence of EpCAM expression in tumors\n# Abstract\n## Study design and cohort\n## EpCAM positivity patterns across tumor categories\n## Comparisons with CKpan and TROP2","[{\"question\":\"What is EpCAM used for in tumor diagnosis?\",\"answer\":\"EpCAM is expressed in many epithelial tumors and is used to distinguish malignant mesotheliomas from adenocarcinomas as a surrogate pan-epithelial marker.\"},{\"question\":\"How was EpCAM expression measured in the study?\",\"answer\":\"A tissue microarray with 14,832 samples from 120 tumor categories was analyzed by immunohistochemistry, and EpCAM staining was compared with TROP2 and CKpan.\"},{\"question\":\"In which tumor types did EpCAM show the lowest staining rates?\",\"answer\":\"EpCAM staining was lowest in hepatocellular carcinomas, adrenocortical tumors, renal cell neoplasms, and poorly differentiated carcinomas.\"}]","Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 Tumors | PDF",1790041092,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54d310bc35c7d117a6319bdbf59dd07a.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77adde5d44573abeec9723947253bcb7.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30a780be164b634fe934e582f6145c66.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c05c1b509b895a6b67694ef36e79799.webp",980,1385]